|
Jul 25
|
Edwards recalls arterial cannulas over exposed wires
|
|
Jul 24
|
Compared to Estimates, Edwards Lifesciences (EW) Q2 Earnings: A Look at Key Metrics
|
|
Jul 24
|
Edwards Lifesciences Reports Second Quarter Results
|
|
Jul 22
|
Robust TMTT Growth to Drive Edwards Lifesciences' Q2 Earnings
|
|
Jul 21
|
Curious about Edwards Lifesciences (EW) Q2 Performance? Explore Wall Street Estimates for Key Metrics
|
|
Jun 30
|
Edwards Lifesciences (NYSE:EW) Removed From Multiple Russell Growth Indexes
|
|
Jun 25
|
Is Edwards Lifesciences Corporation's (NYSE:EW) Stock's Recent Performance A Reflection Of Its Financial Health?
|
|
Jun 17
|
3 Undervalued Asian Small Caps With Insider Buying
|
|
Jun 17
|
ISRG's Minimally Invasive Ecosystem Powers Surgical Precision
|
|
May 6
|
Edwards Lifesciences to Present at the BofA Securities 2025 Health Care Conference
|
|
May 2
|
Edwards Lifesciences (NYSE:EW) Receives FDA Approval For Groundbreaking TAVR Therapy For Asymptomatic Patients
|
|
May 1
|
FDA approves Edwards’ TAVR system for asymptomatic aortic stenosis patients
|
|
May 1
|
Edwards TAVR Receives FDA Approval for Patients With Asymptomatic Severe Aortic Stenosis
|
|
May 1
|
Edwards Lifesciences Corporation (EW): Jim Cramer Says It’s a Hold — But Is Boston Scientific Now His Favorite?
|
|
Feb 25
|
Edwards Lifesciences to Present at the TD Cowen 45th Annual Health Care Conference
|
|
Feb 20
|
Should Edwards Lifesciences Stock Remain in Your Portfolio Now?
|
|
Feb 16
|
The three-year loss for Edwards Lifesciences (NYSE:EW) shareholders likely driven by its shrinking earnings
|
|
Feb 12
|
Edwards Makes A Bullish Move As Heart-Valve Replacements Top $1 Billion
|
|
Feb 12
|
Heart Devices-Focused Edwards Lifesciences Confident in 2025 Outlook, Analyst Sees Long-Term Strength
|
|
Feb 12
|
Q4 2024 Edwards Lifesciences Corp Earnings Call
|